Analyst firms · Morgan Stanley · IVZ

Morgan Stanley IVZ price target and rating history

Invesco Ltd (IVZ) · Finance

Morgan Stanley rates Invesco Ltd (IVZ) Equal-Weight with a $27 price target, as of its latest action on Jan 26, 2022. It has published 4 rating actions on IVZ since July 2021, including 0 upgrades and 0 downgrades. Across 5 firms with a IVZ price target in the last 12 months, the median target is $37.

Current rating
Equal-Weight
Price target
$27
Median target, all firms
$37
Actions on IVZ
4

Morgan Stanley price target on IVZ

$29$28$2720222023202420252026
Morgan Stanley price target on IVZ, each point a stated target, July 2021 to January 2022.

Every Morgan Stanley rating on IVZ

How other firms rate IVZ

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
MizuhoOutperform$37Nov 17, 2026
UBSBuy$41Oct 7, 2026
Keefe, Bruyette & WoodsOutperform$39Sep 9, 2026
Argus ResearchHoldApr 29, 2026
RBC Capital MarketsOutperform$35Jan 21, 2026
Deutsche BankBuy$31Dec 17, 2025

Questions about Morgan Stanley and IVZ

What is Morgan Stanley's price target for IVZ?
Morgan Stanley's latest stated price target for Invesco Ltd (IVZ) is $27, from its action on Jan 26, 2022.
What is Morgan Stanley's rating on IVZ?
Morgan Stanley rates IVZ Equal-Weight, a neutral rating, as of Jan 26, 2022.
When did Morgan Stanley last change its view on IVZ?
On Jan 26, 2022, Morgan Stanley cuts its price target to $27 from $29, keeps Equal-Weight.
How does Morgan Stanley's IVZ target compare with other analysts?
Across 5 firms with a IVZ price target in the last 12 months, the median target is $37.

More IVZ rating histories

All Morgan Stanley ratingsIVZ news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.